Ocular Tolerability of Eudragit RS100® and RL100® Nanosuspensions as Carriers for Ophthalmic Controlled Drug Delivery
- 1 December 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (12) , 2636-2641
- https://doi.org/10.1002/jps.10227
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic applicationBiomaterials, 2002
- Eudragits: Role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiolEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Acrylic Resins as Rate-Controlling Membranes in Novel Formulation of a Nine-Day 17β-Estradiol Transdermal Delivery System: In Vitro and Release Modifier Effect EvaluationDrug Development and Industrial Pharmacy, 2001
- Preparation and Analgesic Activity of Eudragit RS100® Microparticles Containing DiflunisalDrug Delivery, 2001
- The effect of pre-operative topical flurbiprofen or diclofenac on pupil dilatationEye, 2000
- Transdermal Delivery of Propranolol Using Mixed Grades of Eudragit: Design and in Vitro and In Vivo EvaluationDrug Development and Industrial Pharmacy, 2000
- Comparison of the anti‐inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extractionActa Ophthalmologica Scandinavica, 1998
- Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofenJournal of Controlled Release, 1989
- The Effect of Treatment with Topical Nonsteroidal Anti-inflammatory Drugs with and without Intraoperative Epinephrine on the Maintenance of Mydriasis during Cataract SurgeryOphthalmology, 1989
- Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofenJournal of Microencapsulation, 1986